Search research articles
Contact Us
Filters
Showing results (81-90 of 117) with videos related to
Page
of 12
Sort By:
Haematologica
|
July 30, 2013
Syngeneic transplantation in aplastic anemia: pre-transplant conditioning and peripheral blood are associated with improved engraftment: an observational study on behalf of the Severe Aplastic Anemia and Pediatric Diseases Working Parties of the European Group for Blood and Marrow Transplantation
Sabine Gerull, Martin Stern, Jane Apperley, et al.
Leukemia
|
September 17, 2024
Correction: Chronic myeloid leukemia diagnosed in pregnancy: management and outcome of 87 patients reported to the European LeukemiaNet international registry
Ekaterina Chelysheva, Jane Apperley, Anna Turkina, et al.
Leukemia
|
September 2, 2024
Correction: Dose modification dynamics of ponatinib in patients with chronic-phase chronic myeloid leukemia (CP-CML) from the PACE and OPTIC trials
Elias Jabbour, Jane Apperley, Jorge Cortes, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
May 3, 2008
Phase II, open-label study evaluating the activity of imatinib in treating life-threatening malignancies known to be associated with imatinib-sensitive tyrosine kinases
Michael C Heinrich, Heikki Joensuu, George D Demetri, et al.
Transfusion
|
June 27, 2014
Should the standard dimethyl sulfoxide concentration be reduced? Results of a European Group for Blood and Marrow Transplantation prospective noninterventional study on usage and side effects of dimethyl sulfoxide
Curly Morris, Liesbeth de Wreede, Marijke Scholten, et al.
Leukemia
|
February 22, 2024
Chronic myeloid leukemia diagnosed in pregnancy: management and outcome of 87 patients reported to the European LeukemiaNet international registry
Ekaterina Chelysheva, Jane Apperley, Anna Turkina, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation
|
August 17, 2010
Humoral and cellular immunity to primary H1N1 infection in patients with hematologic malignancies following stem cell transplantation
Paula Garland, Hugues de Lavallade, Takuya Sekine, et al.
Science Translational Medicine
|
November 17, 2017
Apoptosis in mesenchymal stromal cells induces in vivo recipient-mediated immunomodulation
Antonio Galleu, Yanira Riffo-Vasquez, Cristina Trento, et al.
American Journal of Hematology
|
September 2, 2022
Ponatinib after failure of second-generation tyrosine kinase inhibitor in resistant chronic-phase chronic myeloid leukemia
Hagop M Kantarjian, Elias Jabbour, Michael Deininger, et al.
Oncogene
|
March 13, 2021
Proteasome 26S subunit, non-ATPases 1 (PSMD1) and 3 (PSMD3), play an oncogenic role in chronic myeloid leukemia by stabilizing nuclear factor-kappa B
Alfonso E Bencomo-Alvarez, Andres J Rubio, Idaly M Olivas, et al.
Page
of 12
Search research articles
Search
Showing results (81-90 of 117) with videos related to
Sort By:
Page
of 12
Haematologica
|
July 30, 2013
Syngeneic transplantation in aplastic anemia: pre-transplant conditioning and peripheral blood are associated with improved engraftment: an observational study on behalf of the Severe Aplastic Anemia and Pediatric Diseases Working Parties of the European Group for Blood and Marrow Transplantation
Sabine Gerull, Martin Stern, Jane Apperley, et al.
Leukemia
|
September 17, 2024
Correction: Chronic myeloid leukemia diagnosed in pregnancy: management and outcome of 87 patients reported to the European LeukemiaNet international registry
Ekaterina Chelysheva, Jane Apperley, Anna Turkina, et al.
Leukemia
|
September 2, 2024
Correction: Dose modification dynamics of ponatinib in patients with chronic-phase chronic myeloid leukemia (CP-CML) from the PACE and OPTIC trials
Elias Jabbour, Jane Apperley, Jorge Cortes, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
May 3, 2008
Phase II, open-label study evaluating the activity of imatinib in treating life-threatening malignancies known to be associated with imatinib-sensitive tyrosine kinases
Michael C Heinrich, Heikki Joensuu, George D Demetri, et al.
Transfusion
|
June 27, 2014
Should the standard dimethyl sulfoxide concentration be reduced? Results of a European Group for Blood and Marrow Transplantation prospective noninterventional study on usage and side effects of dimethyl sulfoxide
Curly Morris, Liesbeth de Wreede, Marijke Scholten, et al.
Leukemia
|
February 22, 2024
Chronic myeloid leukemia diagnosed in pregnancy: management and outcome of 87 patients reported to the European LeukemiaNet international registry
Ekaterina Chelysheva, Jane Apperley, Anna Turkina, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation
|
August 17, 2010
Humoral and cellular immunity to primary H1N1 infection in patients with hematologic malignancies following stem cell transplantation
Paula Garland, Hugues de Lavallade, Takuya Sekine, et al.
Science Translational Medicine
|
November 17, 2017
Apoptosis in mesenchymal stromal cells induces in vivo recipient-mediated immunomodulation
Antonio Galleu, Yanira Riffo-Vasquez, Cristina Trento, et al.
American Journal of Hematology
|
September 2, 2022
Ponatinib after failure of second-generation tyrosine kinase inhibitor in resistant chronic-phase chronic myeloid leukemia
Hagop M Kantarjian, Elias Jabbour, Michael Deininger, et al.
Oncogene
|
March 13, 2021
Proteasome 26S subunit, non-ATPases 1 (PSMD1) and 3 (PSMD3), play an oncogenic role in chronic myeloid leukemia by stabilizing nuclear factor-kappa B
Alfonso E Bencomo-Alvarez, Andres J Rubio, Idaly M Olivas, et al.
Page
of 12